Skip to content

Acharya chemicals

  • Acharya Chemicals & Herbert Brown Pharmaceutical & Research Laboratories have more than 16+ years experience in GMP environment.
  • Class 100,000 clean rooms.
  • APIs available in micronized, jet/pin milled form
  • Solid reagents/intermediates available in tablet/pellet form
  • 2-8℃ Finished goods storage and transportation
  • Separate warehouse for solid and liquid/solvent raw materials
  • APIs being manufactured are Novel polymorphs, extremely moisture sensitive, temperature sensitive
  • All APIs and Intermediates are in Solid form
  • Final API filtration in closed conditions for certain APIs
  • Upto 7 step synthesis manufacturing process being followed for certain APIs
  • APIs and Intermediates being sold in US and European countries
  • Acharya Chemicals received USFDA EIR in May 2024
  • Acharya Chemicals received EUGMP certificate in May 2023

Keeping a close eye on quality

We take pride in being a well-known group company in API, intermediates and nucleosides manufacturing, dedicated to producing high-quality pharmaceutical ingredients for global healthcare solutions. With decades of experience and an unwavering commitment to excellence, we have become a preferred manufacturing partner for pharmaceutical companies worldwide. Our certifications and approvals from EDQM, USFDA, PMDA are a testament to our commitment to delivering safe, reliable, and high-quality APIs.

Pharma - Products

APIs

  • Benzyl Nicotinate (HBPRL)
  • Methyl Nicotinate (HBPRL)
  • Metronidazole Benzoate (AC)
  • Valbenazine Tosylate (AC)
  • Bisoprolol Fumarate (AC)
  • Chlordiazepoxide (only for domestic markets) (HBPRL)

Intermediates (Both GMP & ISO Facilities)

  • Phenyl tert-butyl Nitronme
  • Caronic Anhydride
  • Myosmine
  • 1, 2, 5-Trimethylpiperidine-4-One
  • 2-Aminobenzonitile
  • 2-Amino-5-chlorobenzophenone

Pharma Partner for API and Advanced Intermediates

Commercial Production

  • In house Technology
  • In license Technology

Discovery – Preclinical P1/2/3

  • Process Development

Full Regulatory Support

  • CMC
Back To Top